COPD patients with newer home oxygen prescriptions (within the previous 90 days) are more likely to sustain burn injuries, according to research published in the Mayo Clinic Proceedings.
The inhalation of heroin for recreational purposes appears to be associated with early-onset COPD, and specifically with an emphysema phenotype, according to the results of a recent study.
The study led by Temple University is testing a drug called YPL-001, which contains an herbal extract from a perennial plant called speedwell.
Fifty-five percent of long-term smokers who pass lung function tests still have a respiratory impairment, according to a study published in JAMA Internal Medicine.
Pulmatrix, a clinical stage biopharmaceutical company, has entered into an agreement with Mylan NV for PUR0200, a clinical stage bronchodilator therapy being studied for COPD.
Medical costs associated with COPD are increasing and COPD patients spend on average twice as much in direct medical costs as those without the condition.
Physical activity decreases substantially over time in patients with COPD at all levels of severity and this decline is accompanied by a worsening of lung function and health status.
A new study found that the presence of Pseudomonas aeruginosa was most predictive of bronchiectasis, and that bronchiectasis was predictive of a worse outcome for COPD.
A recently published study in Respiratory Research proposes new potential biomarkers for patients with COPD.
InMed Pharmaceuticals has initiated a program to identify and evaluate cannabinoid compounds for the treatment of COPD, according to a CNN Money news report.
The results of a new study indicate that saliva may be a reliable bio-sample in the monitoring of patients with COPD and exacerbation management.
Researchers recommend that pulmonary rehabilitation programs for patients with COPD should include sleep assessment.
Order sets, or a checklist of steps, was shown to help patients with worsening COPD spend less time in the hospital when used by a physician.
German researchers from University of Munich recently identified a genetic mutation in the SERPINA-1 gene linked to alpha-1 antitrypsin deficiency in a patient previously diagnosed with COPD and being treated for bronchiectasis.
Project HOPE and AstraZenaca will establish the China Alliance of Respiratory Diseases Prevention and Treatment program to treat chronic respiratory diseases in China.
A study reveals that increases in systemic inflammation predict more frequent exacerbations in patients with asthma and airway Interluekin-1β in patients with COPD.
Mucus dehydration may lead to reduced mucociliary clearance and symptoms of chronic bronchitis, according to new research published in AJRCCM.
The US FDA has approved Stiolto Respimat (tiotropium bromide and olodaterol) Inhalation Spray as a long-term, once-daily maintenance treatment of airflow obstruction in patients with COPD.
Novartis' investigational combination indacaterol/glycopyrronium bromide therapy for COPD performed better than its constituent components in a Phase III clinical trial.
For a small percentage of chronic lung disease patients, the environment -- not smoking or genetics -- plays the primary role in their development of the disease.